Mediwound Ltd (MDWD)

Currency in USD
13.610
-0.070(-0.51%)
Closed·
13.6100.000(0.00%)
·
MDWD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.59514.100
52 wk Range
11.80019.700
Key Statistics
Prev. Close
13.68
Open
13.6
Day's Range
13.595-14.1
52 wk Range
11.8-19.7
Volume
167.64K
Average Volume (3m)
121.63K
1-Year Change
-25.547%
Book Value / Share
2.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDWD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.667
Upside
+117.98%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Mediwound Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.667
(+117.98% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy30.00+120.43%36.00MaintainNov 13, 2026
TD Cowen
Buy25.00+83.69%-MaintainSep 24, 2026
Oppenheimer
Buy30.00+120.43%32.00MaintainAug 14, 2026
Oppenheimer
Buy32.00+135.12%33.00MaintainMay 27, 2026
H.C. Wainwright
Buy36.00+164.51%31.00MaintainNov 21, 2025

Mediwound Ltd Earnings Call Summary for Q3/2026

  • MediWound Q3 2026 revenue plunged 33% to $3.57M, missing estimates by 49%; adjusted loss of $0.65/share beat forecasts by 8.5%
  • Gross margin surged to 28.5% from 16.5% on favorable revenue mix; R&D spending jumped 77% to advance EscharEx phase III VALUE trial
  • Cash declined to $28.4M from $53.6M year-end 2025; NexoBrid sales constrained by manufacturing capacity despite strong demand
  • EscharEx VALUE trial enrollment expected to complete Q1 2027 with mid-2027 data readout; company maintains $24M-$26M 2027 revenue guidance
  • Shares fell 6.51% to $12.92 on revenue miss; management keeping partnership and independent launch options open post-trial results
Last Updated: 12/11/2026, 16:06
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.65 / -0.71
Revenue / Forecast
3.57M / 6.94M
EPS Revisions
Last 90 days

MDWD Income Statement

Compare MDWD to Peers and Sector

Metrics to compare
MDWD
Peers
Sector
Relationship
P/E Ratio
−8.3x−0.6x−0.2x
PEG Ratio
0.22−0.030.00
Price/Book
6.1x0.9x2.6x
Price / LTM Sales
19.4x2.0x2.7x
Upside (Analyst Target)
118.0%117.8%68.5%
Fair Value Upside
Unlock19.2%11.5%Unlock

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Employees
121

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.99M13.95%26.99M
Other Institutional Investors
9.55M66.84%129.44M
Public Companies & Retail Investors
2.75M19.21%37.20M
Total
14.29M100.00%193.63M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HOLD Fund Management Ltd9.44%1,348,32318,270
Clal Life Sciences L.P.8.21%1,172,71015,890

People Also Watch

56.400
LQDA
-0.58%
7.220
PBYI
+1.12%
4.500
CRMD
-3.64%
136.86
DTE
+0.33%
3.920
IRD
-3.21%

FAQ

What Is the Mediwound (MDWD) Stock Price Today?

The Mediwound stock price today is 13.610 USD.

What Stock Exchange Does Mediwound Trade On?

Mediwound is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Mediwound?

The stock symbol for Mediwound is "MDWD."

What Is the Mediwound Market Cap?

As of today, Mediwound market cap is 195.490M USD.

What Is Mediwound's Earnings Per Share (TTM)?

The Mediwound EPS (TTM) is -1.82.

When Is the Next Mediwound Earnings Date?

Mediwound will release its next earnings report on Mar 18, 2027.

From a Technical Analysis Perspective, Is MDWD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Mediwound Stock Split?

Mediwound has split 1 times.

How Many Employees Does Mediwound Have?

Mediwound has 121 employees.

What is the current trading status of Mediwound (MDWD)?

As of Nov 19, 2026, Mediwound (MDWD) is trading at a price of 13.610 USD, with a previous close of 13.680 USD. The stock has fluctuated within a day range of 13.595 USD to 14.100 USD, while its 52-week range spans from 11.800 USD to 19.700 USD.

What Is Mediwound (MDWD) Price Target According to Analysts?

The average 12-month price target for Mediwound is 29.667 USD, with a high estimate of 36 USD and a low estimate of 25 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +117.98% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.